Li Na, Li Tiejun, Xiong Lu, et al. Effects of Dexmedetomidine on Myocardial and Brain Injury in Children with Congenital Heart Disease during Perioperative Perio. [J]. 26(10):11-14(2020)
DOI:
Li Na, Li Tiejun, Xiong Lu, et al. Effects of Dexmedetomidine on Myocardial and Brain Injury in Children with Congenital Heart Disease during Perioperative Perio. [J]. 26(10):11-14(2020) DOI: 10.13407/j.cnki.jpp.1672-108X.2020.10.004.
Effects of Dexmedetomidine on Myocardial and Brain Injury in Children with Congenital Heart Disease during Perioperative Perio
Objective: To probe into the effects of dexmedetomidine on hemodynamics
myocardial and brain function indexes in children with congenital heart disease during perioperative period. Methods: A total of 98 children with atrial septal defect or ventricular septal defect admitted into Hainan General Hospital and West China Second University Hospital
Sichuan University from Aug. 2016 to Aug. 2018 were extracted to be randomly divided into the observation group and the control group
with 49 cases in each group. The control group received conventional anesthesia
tracheal intubation and mechanical ventilation. The observation group was given intravenous injection of dexmedetomidine at a dose of 0.5 μg/(kg·h) on the basis of the control group until the surgery was completed. Hemodynamic indicators (heart rate
systolic blood pressure and diastolic blood pressure) were measured before cardiopulmonary bypass (CPB) surgery (T1)
10 minutes after CPB (T2)
6 hours after CPB (T3)
and 12 hours after CPB (T4). Blood was collected at the four time points. Levels of S-100β and neuron-specific enolase (NSE)
ischemia-modified albumin (IMA) and cardiac troponin I (cTnI) were detected by ELISA. Results: Compared with the control group
the heart rate of the observation group decreased at T2 and T3 (P<0.05)
while systolic and diastolic blood pressure increased (P<0.01). The levels of IMA
cTnI
S-100β and NSE in the observation group decreased at T2
T3
and T4 (P<0.01). Compared with T1
the heart rate increased at T2 and T3 in the observation group (P<0.05). There was no significant difference between systolic blood pressure and diastolic blood pressure at each time point (P>0.05). The levels of IMA
cTnI
S-100β and NSE increased significantly at T2
T3 and T4 (P<0.05). Conclusion: Dexmedetomidine can maintain the stability of arterial blood pressure in children with congenital heart disease
reduce the heart rate
improve the myocardial damage
and decrease the levels of NSE and S-100β protein.
Effects of Dexmedetomidine Nasal Drops Combined with Sevoflurane Inhalation Induction on Cerebral Oxygen Metabolism and Cognitive Function in Children Undergoing Interventional Occlusion of Congenital Heart Disease
Comparison on Effects of Different Doses of Dexmedetomidine on Emergency Agitation and Hemodynamicsin Children with OSAHS after Palatopharyngoplasty
Effects of Remifentanil Combined with Low-Dose Sufentanil on Hemodynamics and Postoperative Anesthesia Recovery in Interventional Surgery for Congenital Heart Disease in Children
Application and Safety of Preoperative Administration of Different Doses of Dexmedetomidine in Children Undergoing Endoscopic-Assisted Transoral Adenoidectomy
Meta-Analysis of Efficacy and Safety of Milrinoneon Injection in the Treatment of Children with Congenital Heart Disease Complicated with Severe Pneumonia and Heart Failure
Related Author
Pang Xiaoyi
Liu Hong
Du Qian
Wen Xu
Wang Rong
Zhang Wenjing
Kong Jianqiang
Wang Jiansheng
Related Institution
Mianyang 404 Hospital
Shanghai Baoshan Hospital of Integrated Traditional Chinese Medicine andWestern Medicine, Shanghai